Dezhan Healthcare Company Limited (SHE:000813)

China flag China · Delayed Price · Currency is CNY
4.050
0.00 (0.00%)
Aug 22, 2025, 3:04 PM CST
Market Cap8.38B
Revenue (ttm)454.51M
Net Income (ttm)-25.72M
Shares Out2.07B
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume51,528,484
Average Volume141,298,560
Open4.240
Previous Close4.050
Day's Range4.000 - 4.240
52-Week Range2.250 - 5.260
Beta0.25
RSI49.15
Earnings DateAug 25, 2025

About Dezhan Healthcare Company

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet. It is also involved in the provision of biological peptides, industrial hemp, and medica... [Read more]

Sector Healthcare
Founded 1980
Employees 1,054
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000813
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.